Global Artificial Insemination Market- Industry Analysis and Forecast (2020-2027) – By Type, Source, End User, and Region.

Global Artificial Insemination Market was valued at US$ 1.60 Bn in 2019 and is expected to reach US$ 2.80 Bn by 2027, at a CAGR of 7.25 % during a forecast period.   Global Artificial Insemination Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers, and market disrupters in the report, and the same is reflected in our analysis. The Artificial insemination is a fertility treatment method. It is used to deliver sperm directly to the cervix or uterus and this technique helps infertile couples conceive. This is based on insertion of sperm from male to facilitate smooth fertilization of the woman’s ovum.

Global Artificial Insemination Market, Dynamics:

The issue of Infertility is one of the major and serious concern across the globe which is growing amongst the youth. The female preference for pregnancy and gradual rise in the number of sub-fertile couples who require help with pregnancy, can be considered as the factors behind the market growth. The age, the quality of eggs in the women and also those women who are in their late 30s are expected to increase the demand for artificial insemination. On the other hand, a few risks associated with artificial insemination are expected to limit the market growth. The multiple births can occur and there is a greater chance of the woman giving birth to twins or triplets. Multiple births are expected to increase the chances of complications like premature birth or miscarriage. Currently, fertility medication is used only in cases where endometriosis appears to be the cause of infertility. The female prefers the artificial insemination kits, which is successful in about 30% of cases. A doctor can recommend additionally, a treatment for fertility which is called as invitro fertilization (IVF). It is used as extracting eggs from a woman and sperm from a man. It is referred as substitute for the artificial insemination that expected to hamper the market growth.

Global Artificial Insemination Market, Segment Analysis:

Artificial Insemination has aimed at couples who suffer infertility problems because of the mild male factor dysfunction. It is also used for unexplained mild infertility. Artificial Insemination market is segmented in artificial insemination with homologous (AIH) and donor artificial insemination (AID). In AIH, the fertility is achieved by insertion of sperm from the husband and the second is donor artificial insemination (AID). It includes artificial insemination of a woman with sperm from an anonymous donor where the husband is found to be sterile. Home insemination is the method of reproductive tract without sexual intercourse where the Couples usually succeed by using a syringe to inseminate the prospective mother. People can also purchase at-home Artificial Insemination kits. The kits come with items like containers for semen and syringes to collect the semen. The process is straightforward and can be difficult for a woman to perform it by her own. It can take few attempts before successful conception. Fertility clinics are adopting numerous strategies to build knowledge and awareness about available treatment and solutions for infertility problems to increase their customer case. The number of medical centers is focusing to offer infertility treatment because of growth in infertility rates across the globe.

Global Artificial Insemination Market, Regional Analysis:

North American region is expected to grow at a XX% rate of CAGR during the forecast period. The growth in the market can be attributed to the female preference for artificial insemination across the region. An increase in awareness about infertility treatments available in the market, growth in the infertility rate are expected to boost the regional growth by Artificial Insemination. In America, no national law regulates Third Party Reproduction. According to the Association Society for Reproductive Medicine, access to ART should be granted to them who are considered fit for parenting. The objective of the report is to present a comprehensive analysis of the Global Artificial Insemination Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Artificial Insemination Market dynamics, structure by analyzing the market segments and projects the Global Artificial Insemination Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Artificial Insemination Market make the report investor’s guide.

Scope of the Global Artificial Insemination Market: Inquire before buying

Global Artificial Insemination Market, By Type

• Intrauterine • Intracervical • Intravaginal • Intratubal

Global Artificial Insemination Market, By Source

• AIH-Husband • AID-Donor

Global Artificial Insemination Market, By End User

• Fertility Clinics & Other Facilities • Home

Global Artificial Insemination Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in Global Artificial Insemination Market

• Vitrolife • Genea Limited • Rinovum Women’s Health, Llc • Pride Angel • Fujifilm Irvine Scientific • Kitazato Corporation • Rocket Medical Plc • Invo Bioscience • Medgyn Products, Inc
Global Artificial Insemination Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Artificial Insemination Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Artificial Insemination Market Analysis and Forecast 6.1. Artificial Insemination Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Artificial Insemination Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Artificial Insemination Market Value Share Analysis, By Type 7.4. Artificial Insemination Market Size (US$ Bn) Forecast, By Type 7.5. Artificial Insemination Market Analysis, By Type 7.6. Artificial Insemination Market Attractiveness Analysis, By Type 8. Global Artificial Insemination Market Analysis and Forecast, By Source 8.1. Introduction and Definition 8.2. Key Findings 8.3. Artificial Insemination Market Value Share Analysis, By Source 8.4. Artificial Insemination Market Size (US$ Bn) Forecast, By Source 8.5. Artificial Insemination Market Analysis, By Source 8.6. Artificial Insemination Market Attractiveness Analysis, By Source 9. Global Artificial Insemination Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Artificial Insemination Market Value Share Analysis, By End User 9.4. Artificial Insemination Market Size (US$ Bn) Forecast, By End User 9.5. Artificial Insemination Market Analysis, By End User 9.6. Artificial Insemination Market Attractiveness Analysis, By End User 10. Global Artificial Insemination Market Analysis, by Region 10.1. Artificial Insemination Market Value Share Analysis, by Region 10.2. Artificial Insemination Market Size (US$ Bn) Forecast, by Region 10.3. Artificial Insemination Market Attractiveness Analysis, by Region 11. North America Artificial Insemination Market Analysis 11.1. Key Findings 11.2. North America Artificial Insemination Market Overview 11.3. North America Artificial Insemination Market Value Share Analysis, By Type 11.4. North America Artificial Insemination Market Forecast, By Type 11.4.1. Intrauterine 11.4.2. Intracervical 11.4.3. Intravaginal 11.4.4. Intratubal 11.5. North America Artificial Insemination Market Value Share Analysis, By Source 11.6. North America Artificial Insemination Market Forecast, By Source 11.6.1. AIH-Husband 11.6.2. AID-Donor 11.7. North America Artificial Insemination Market Value Share Analysis, By End User 11.8. North America Artificial Insemination Market Forecast, By End User 11.8.1. Fertility Clinics & Other Facilities 11.8.2. Home 11.9. North America Artificial Insemination Market Value Share Analysis, by Country 11.10. North America Artificial Insemination Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Artificial Insemination Market Analysis, by Country 11.12. U.S. Artificial Insemination Market Forecast, By Type 11.12.1. Intrauterine 11.12.2. Intracervical 11.12.3. Intravaginal 11.12.4. Intratubal 11.13. U.S. Artificial Insemination Market Forecast, By Source 11.13.1. AIH-Husband 11.13.2. AID-Donor 11.14. U.S. Artificial Insemination Market Forecast, By End User 11.14.1. Fertility Clinics & Other Facilities 11.14.2. Home 11.15. Canada Artificial Insemination Market Forecast, By Type 11.15.1. Intrauterine 11.15.2. Intracervical 11.15.3. Intravaginal 11.15.4. Intratubal 11.16. Canada Artificial Insemination Market Forecast, By Source 11.16.1. AIH-Husband 11.16.2. AID-Donor 11.17. Canada Artificial Insemination Market Forecast, By End User 11.17.1. Fertility Clinics & Other Facilities 11.17.2. Home 11.18. North America Artificial Insemination Market Attractiveness Analysis 11.18.1. By Type 11.18.2. By Source 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Artificial Insemination Market Analysis 12.1. Key Findings 12.2. Europe Artificial Insemination Market Overview 12.3. Europe Artificial Insemination Market Value Share Analysis, By Type 12.4. Europe Artificial Insemination Market Forecast, By Type 12.4.1. Intrauterine 12.4.2. Intracervical 12.4.3. Intravaginal 12.4.4. Intratubal 12.5. Europe Artificial Insemination Market Value Share Analysis, By Source 12.6. Europe Artificial Insemination Market Forecast, By Source 12.6.1. AIH-Husband 12.6.2. AID-Donor 12.7. Europe Artificial Insemination Market Value Share Analysis, By End User 12.8. Europe Artificial Insemination Market Forecast, By End User 12.8.1. Fertility Clinics & Other Facilities 12.8.2. Home 12.9. Europe Artificial Insemination Market Value Share Analysis, by Country 12.10. Europe Artificial Insemination Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Artificial Insemination Market Analysis, by Country 12.12. Germany Artificial Insemination Market Forecast, By Type 12.12.1. Intrauterine 12.12.2. Intracervical 12.12.3. Intravaginal 12.12.4. Intratubal 12.13. Germany Artificial Insemination Market Forecast, By Source 12.13.1. AIH-Husband 12.13.2. AID-Donor 12.14. Germany Artificial Insemination Market Forecast, By End User 12.14.1. Fertility Clinics & Other Facilities 12.14.2. Home 12.15. U.K. Artificial Insemination Market Forecast, By Type 12.15.1. Intrauterine 12.15.2. Intracervical 12.15.3. Intravaginal 12.15.4. Intratubal 12.16. U.K. Artificial Insemination Market Forecast, By Source 12.16.1. AIH-Husband 12.16.2. AID-Donor 12.17. U.K. Artificial Insemination Market Forecast, By End User 12.17.1. Fertility Clinics & Other Facilities 12.17.2. Home 12.18. France Artificial Insemination Market Forecast, By Type 12.18.1. Intrauterine 12.18.2. Intracervical 12.18.3. Intravaginal 12.18.4. Intratubal 12.19. France Artificial Insemination Market Forecast, By Source 12.19.1. AIH-Husband 12.19.2. AID-Donor 12.20. France Artificial Insemination Market Forecast, By End User 12.20.1. Fertility Clinics & Other Facilities 12.20.2. Home 12.21. Italy Artificial Insemination Market Forecast, By Type 12.21.1. Intrauterine 12.21.2. Intracervical 12.21.3. Intravaginal 12.21.4. Intratubal 12.22. Italy Artificial Insemination Market Forecast, By Source 12.22.1. AIH-Husband 12.22.2. AID-Donor 12.23. Italy Artificial Insemination Market Forecast, By End User 12.23.1. Fertility Clinics & Other Facilities 12.23.2. Home 12.24. Spain Artificial Insemination Market Forecast, By Type 12.24.1. Intrauterine 12.24.2. Intracervical 12.24.3. Intravaginal 12.24.4. Intratubal 12.25. Spain Artificial Insemination Market Forecast, By Source 12.25.1. AIH-Husband 12.25.2. AID-Donor 12.26. Spain Artificial Insemination Market Forecast, By End User 12.26.1. Fertility Clinics & Other Facilities 12.26.2. Home 12.27. Rest of Europe Artificial Insemination Market Forecast, By Type 12.27.1. Intrauterine 12.27.2. Intracervical 12.27.3. Intravaginal 12.27.4. Intratubal 12.28. Rest of Europe Artificial Insemination Market Forecast, By Source 12.28.1. AIH-Husband 12.28.2. AID-Donor 12.29. Rest of Europe Artificial Insemination Market Forecast, By End User 12.29.1. Fertility Clinics & Other Facilities 12.29.2. Home 12.30. Europe Artificial Insemination Market Attractiveness Analysis 12.30.1. By Type 12.30.2. By Source 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Artificial Insemination Market Analysis 13.1. Key Findings 13.2. Asia Pacific Artificial Insemination Market Overview 13.3. Asia Pacific Artificial Insemination Market Value Share Analysis, By Type 13.4. Asia Pacific Artificial Insemination Market Forecast, By Type 13.4.1. Intrauterine 13.4.2. Intracervical 13.4.3. Intravaginal 13.4.4. Intratubal 13.5. Asia Pacific Artificial Insemination Market Value Share Analysis, By Source 13.6. Asia Pacific Artificial Insemination Market Forecast, By Source 13.6.1. AIH-Husband 13.6.2. AID-Donor 13.7. Asia Pacific Artificial Insemination Market Value Share Analysis, By End User 13.8. Asia Pacific Artificial Insemination Market Forecast, By End User 13.8.1. Fertility Clinics & Other Facilities 13.8.2. Home 13.9. Asia Pacific Artificial Insemination Market Value Share Analysis, by Country 13.10. Asia Pacific Artificial Insemination Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Artificial Insemination Market Analysis, by Country 13.12. China Artificial Insemination Market Forecast, By Type 13.12.1. Intrauterine 13.12.2. Intracervical 13.12.3. Intravaginal 13.12.4. Intratubal 13.13. China Artificial Insemination Market Forecast, By Source 13.13.1. AIH-Husband 13.13.2. AID-Donor 13.14. China Artificial Insemination Market Forecast, By End User 13.14.1. Fertility Clinics & Other Facilities 13.14.2. Home 13.15. India Artificial Insemination Market Forecast, By Type 13.15.1. Intrauterine 13.15.2. Intracervical 13.15.3. Intravaginal 13.15.4. Intratubal 13.16. India Artificial Insemination Market Forecast, By Source 13.16.1. AIH-Husband 13.16.2. AID-Donor 13.17. India Artificial Insemination Market Forecast, By End User 13.17.1. Fertility Clinics & Other Facilities 13.17.2. Home 13.18. Japan Artificial Insemination Market Forecast, By Type 13.18.1. Intrauterine 13.18.2. Intracervical 13.18.3. Intravaginal 13.18.4. Intratubal 13.19. Japan Artificial Insemination Market Forecast, By Source 13.19.1. AIH-Husband 13.19.2. AID-Donor 13.20. Japan Artificial Insemination Market Forecast, By End User 13.20.1. Fertility Clinics & Other Facilities 13.20.2. Home 13.21. ASEAN Artificial Insemination Market Forecast, By Type 13.21.1. Intrauterine 13.21.2. Intracervical 13.21.3. Intravaginal 13.21.4. Intratubal 13.22. ASEAN Artificial Insemination Market Forecast, By Source 13.22.1. AIH-Husband 13.22.2. AID-Donor 13.23. ASEAN Artificial Insemination Market Forecast, By End User 13.23.1. Fertility Clinics & Other Facilities 13.23.2. Home 13.24. Rest of Asia Pacific Artificial Insemination Market Forecast, By Type 13.24.1. Intrauterine 13.24.2. Intracervical 13.24.3. Intravaginal 13.24.4. Intratubal 13.25. Rest of Asia Pacific Artificial Insemination Market Forecast, By Source 13.25.1. AIH-Husband 13.25.2. AID-Donor 13.26. Rest of Asia Pacific Artificial Insemination Market Forecast, By End User 13.26.1. Fertility Clinics & Other Facilities 13.26.2. Home 13.27. Asia Pacific Artificial Insemination Market Attractiveness Analysis 13.27.1. By Type 13.27.2. By Source 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Artificial Insemination Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Artificial Insemination Market Overview 14.3. Middle East & Africa Artificial Insemination Market Value Share Analysis, By Type 14.4. Middle East & Africa Artificial Insemination Market Forecast, By Type 14.4.1. Intrauterine 14.4.2. Intracervical 14.4.3. Intravaginal 14.4.4. Intratubal 14.5. Middle East & Africa Artificial Insemination Market Value Share Analysis, By Source 14.6. Middle East & Africa Artificial Insemination Market Forecast, By Source 14.6.1. AIH-Husband 14.6.2. AID-Donor 14.7. Middle East & Africa Artificial Insemination Market Value Share Analysis, By End User 14.8. Middle East & Africa Artificial Insemination Market Forecast, By End User 14.8.1. Fertility Clinics & Other Facilities 14.8.2. Home 14.9. Middle East & Africa Artificial Insemination Market Value Share Analysis, by Country 14.10. Middle East & Africa Artificial Insemination Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Artificial Insemination Market Analysis, by Country 14.12. GCC Artificial Insemination Market Forecast, By Type 14.12.1. Intrauterine 14.12.2. Intracervical 14.12.3. Intravaginal 14.12.4. Intratubal 14.13. GCC Artificial Insemination Market Forecast, By Source 14.13.1. AIH-Husband 14.13.2. AID-Donor 14.14. GCC Artificial Insemination Market Forecast, By End User 14.14.1. Fertility Clinics & Other Facilities 14.14.2. Home 14.15. South Africa Artificial Insemination Market Forecast, By Type 14.15.1. Intrauterine 14.15.2. Intracervical 14.15.3. Intravaginal 14.15.4. Intratubal 14.16. South Africa Artificial Insemination Market Forecast, By Source 14.16.1. AIH-Husband 14.16.2. AID-Donor 14.17. South Africa Artificial Insemination Market Forecast, By End User 14.17.1. Fertility Clinics & Other Facilities 14.17.2. Home 14.18. Rest of Middle East & Africa Artificial Insemination Market Forecast, By Type 14.18.1. Intrauterine 14.18.2. Intracervical 14.18.3. Intravaginal 14.18.4. Intratubal 14.19. Rest of Middle East & Africa Artificial Insemination Market Forecast, By Source 14.19.1. AIH-Husband 14.19.2. AID-Donor 14.20. Rest of Middle East & Africa Artificial Insemination Market Forecast, By End User 14.20.1. Fertility Clinics & Other Facilities 14.20.2. Home 14.21. Middle East & Africa Artificial Insemination Market Attractiveness Analysis 14.21.1. By Type 14.21.2. By Source 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Artificial Insemination Market Analysis 15.1. Key Findings 15.2. South America Artificial Insemination Market Overview 15.3. South America Artificial Insemination Market Value Share Analysis, By Type 15.4. South America Artificial Insemination Market Forecast, By Type 15.4.1. Intrauterine 15.4.2. Intracervical 15.4.3. Intravaginal 15.4.4. Intratubal 15.5. South America Artificial Insemination Market Value Share Analysis, By Source 15.6. South America Artificial Insemination Market Forecast, By Source 15.6.1. AIH-Husband 15.6.2. AID-Donor 15.7. South America Artificial Insemination Market Value Share Analysis, By End User 15.8. South America Artificial Insemination Market Forecast, By End User 15.8.1. Fertility Clinics & Other Facilities 15.8.2. Home 15.9. South America Artificial Insemination Market Value Share Analysis, by Country 15.10. South America Artificial Insemination Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Artificial Insemination Market Analysis, by Country 15.12. Brazil Artificial Insemination Market Forecast, By Type 15.12.1. Intrauterine 15.12.2. Intracervical 15.12.3. Intravaginal 15.12.4. Intratubal 15.13. Brazil Artificial Insemination Market Forecast, By Source 15.13.1. AIH-Husband 15.13.2. AID-Donor 15.14. Brazil Artificial Insemination Market Forecast, By End User 15.14.1. Fertility Clinics & Other Facilities 15.14.2. Home 15.15. Mexico Artificial Insemination Market Forecast, By Type 15.15.1. Intrauterine 15.15.2. Intracervical 15.15.3. Intravaginal 15.15.4. Intratubal 15.16. Mexico Artificial Insemination Market Forecast, By Source 15.16.1. AIH-Husband 15.16.2. AID-Donor 15.17. Mexico Artificial Insemination Market Forecast, By End User 15.17.1. Fertility Clinics & Other Facilities 15.17.2. Home 15.18. Rest of South America Artificial Insemination Market Forecast, By Type 15.18.1. Intrauterine 15.18.2. Intracervical 15.18.3. Intravaginal 15.18.4. Intratubal 15.19. Rest of South America Artificial Insemination Market Forecast, By Source 15.19.1. AIH-Husband 15.19.2. AID-Donor 15.20. Rest of South America Artificial Insemination Market Forecast, By End User 15.20.1. Fertility Clinics & Other Facilities 15.20.2. Home 15.21. South America Artificial Insemination Market Attractiveness Analysis 15.21.1. By Type 15.21.2. By Source 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Sources and R&D investment 16.2.2. New Application Launches and Application Enhancements 16.2.3. Market Consolidation 16.2.4. M&A by Regions, Investment and Sources 16.2.5. M&A Key Players, Forward Support & Maintenance and Backward Support & Maintenance 16.3. Company Profiles: Key Players 16.3.1. Vitrolife 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Source Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Genea Limited 16.3.3. Rinovum Women’s Health, Llc 16.3.4. Pride Angel 16.3.5. Fujifilm Irvine Scientific 16.3.6. Kitazato Corporation 16.3.7. Rocket Medical Plc 16.3.8. Invo Bioscience 16.3.9. Medgyn Products, Inc

About This Report

Report ID 67839
Category Healthcare
Published Date August 2020
Updated Date
Contact Us